Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Gains from Sales and Divestitures (2021 - 2026)

Rani Therapeutics Holdings' Gains from Sales and Divestitures history spans 6 years, with the latest figure at $123389.0 for Q1 2026.

  • On a quarterly basis, Gains from Sales and Divestitures fell 21.35% to $123389.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $123389.0, a 21.35% decrease, with the full-year FY2025 number at $3257.0, down 99.17% from a year prior.
  • Gains from Sales and Divestitures came in at $123389.0 for Q1 2026, up from $3257.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $590713.0 in Q4 2023, with the low at $3257.0 in Q4 2025.
  • Historically, Gains from Sales and Divestitures has averaged $196516.0 across 5 years, with a median of $186315.5 in 2025.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 1677.46% in 2022 and later crashed 99.17% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $267650.0 in 2022, then surged by 120.7% to $590713.0 in 2023, then crashed by 33.17% to $394760.0 in 2024, then tumbled by 99.17% to $3257.0 in 2025, then surged by 3688.42% to $123389.0 in 2026.
  • Business Quant data shows Gains from Sales and Divestitures for RANI at $123389.0 in Q1 2026, $3257.0 in Q4 2025, and $273546.0 in Q3 2025.